Topiramate as a Treatment for Levodopa-Induced Dyskinesia in Parkinson's Disease

NCT00296959 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

20

Enrollment

OTHER

Sponsor class

Stopped early termination due to slow recruitment

Conditions

Parkinson's Disease

Interventions

DRUG: topiramate (drug)

Sponsor

University Health Network, Toronto